Home
Resources
Publications
Assessment of Radioactive Residues Arising From Radiolabel Instability in a Multiple Dose Tissue Distribution Study in Rats

Assessment of Radioactive Residues Arising From Radiolabel Instability in a Multiple Dose Tissue Distribution Study in Rats

John Gregory Slatter, James Peter Sams, John Alan Easter, Gwendolyn Deane Fate, Koji Chiba, Mark Gerard Johnson, Maria Courtney, Michael Dennis Koets, Lorrie Renee Norris, Brian Wayne Jones

Biol Pharm Bull. 2003 May;26(5):573-8.

PMID: 12736492

Abstract:

Our study objectives were: To quantitatively determine the effect of radiolabel instability on terminal phase radioactive tissue residues in a multiple dose tissue distribution study. To quantitatively compare tissue residue artifacts (non drug-related radioactivity) from two chemically-distinct radiolabel locations. To conduct a definitive multiple dose tissue distribution study using the better of the two radiolabeled compounds. We compared the excretion and tissue distribution in rats of [(14)C]linezolid, radiolabeled in two different locations, after 7 consecutive once daily [(14)C] oral doses. The radiolabels were in the acetamide (two carbon) and oxazolidinone (isolated carbon) functional groups. Terminal phase tissue residue and excretion data were compared to data from rats dosed orally with [(14)C]sodium acetate. Drug-related radioactivity was excreted rapidly over 24 h. After a single dose, the acetamide and oxazolidinone radiolabel sites both gave 3% of dose as exhaled (14)CO(2). After 7 daily [(14)C] oral doses, terminal phase radioactive tissue residues were higher from the acetamide radiolabel, relative to the oxazolidinone radiolabel, and were primarily not drug-related. In the definitive tissue distribution study, low concentrations of drug-related radioactivity in skin and thyroid were observed. We conclude that although small amounts of radiolabel instability do not significantly affect single dose tissue radioactivity C(max) and AUC, artifacts arising from radiolabel instability can prolong the apparent terminal phase half life and complicate study data interpretation. When possible, it is always preferable to use a completely stable radiolabel site.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP168828908	Linezolid Related Compound C		168828-90-8	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: